Purpose. During reactive hyperemia, the brachial artery in some individuals constricts prior to dilation. Our aim was to describe the frequency of high-flow-mediated constriction (H-FMC) in adults, and its relationship to body composition and biomarkers of cardiovascular and metabolic risk.
INTRODUCTION
C ardiovascular disease is the leading cause of death worldwide. 1 In 2008, over 75% of the 17.3 million cardiovascular disease deaths were attributed to manifestations of atherosclerosis, an underlying process that narrows and hardens blood vessels. 1 Endothelial dysfunction has been shown to be an important precursor in the atherosclerotic process. 2 Flow-mediated dilation (FMD) is widely used as a noninvasive method for measurement of endothelial health in children and adults. 3 Previously, we reported that 67% of children demonstrate vasoconstriction prior to a shear stress-induced nitric oxide (NO)-mediated dilation of the brachial artery during an FMD assessment. 4 This appears as a biphasic response when plotting the arterial diameter change in response to reactive hyperemia (Figure 1 ). This physiologic response has been referred to as a high-flow-mediated constriction (H-FMC). 4, 5 It has been postulated that the observed vasoconstriction could result from a hemodynamic effect of increased blood flow leading to decreased transmural pressure and/ or a shear stress-stimulated constrictor release, such as endothelin-1. [4] [5] [6] [7] [8] This biphasic response of the brachial artery has previously been reported in adult males during reactive hyperemia. 6 To our knowledge, no published work has reported on the frequency and magnitude of brachial artery H-FMC observed in a healthy adult male and female population or the impact of an H-FMC on peak FMD. Additionally, the relationship of biomarkers of cardiovascular and metabolic health and H-FMC has not been elucidated. The presence of an H-FMC could negatively affect peak FMD such that the response to reactive hyperemia in healthy individuals could appear similar to that of individuals with endothelial dysfunction and increased cardiovascular risk. 9 The purpose of this study was to describe the frequency and magnitude of an H-FMC during reactive hyperemia in healthy adult males and females. In addition, we sought to examine the relationship of H-FMC to FMD, biomarkers of cardiovascular and metabolic risk as well as measures of body composition. We hypothesized that an H-FMC affects peak FMD and is significantly correlated with body composition as well as known cardiovascular and metabolic risk factors.
MATERIALS AND METHODS

Study Population
The 246 adults (124 males, 122 females) in this study were randomly sampled from two population-based longitudinal studies investigating the development of obesity and insulin resistance and their interaction with associated cardiovascular risk factors. 10, 11 Subjects who smoked or were taking prescription medications, such as blood pressure, insulin, dyslipidemia, or statin medication, were excluded from the study. The study protocol was reviewed and approved by an institutional review board, and all participants gave written informed consent.
Physical Assessments
Measurements for height and weight were obtained with a standard stadiometer (model S100; Ayrton, Prior Lake, MN) and electronic scale (Serial No. 5022-8893; ST Scale-Tronix, White Plains, NY), respectively. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared.
Dual-Energy X-ray Absorptiometry
Body composition was measured using a dualenergy X-ray absorptiometer (DXA; Lunar iDXA platform V 13.6; GE Healthcare, Madison, WI). The total body scan was analyzed using the enCore CoreScan software. Standard imaging and positioning protocols were implemented while subjects were fasted and hydrated. Proprietary software algorithms from the manufacturer were used to segment and analyze the body into upper and lower extremities using the standard regions of interest and then combined for each of the measures of interest: lean mass, fat mass, visceral adipose tissue mass (VAT), android fat, gynoid fat, subcutaneous (subQ) fat, and bone mass. Android fat was calculated between the ribs and the top of the pelvis, while the gynoid fat was determined from the upper thighs to the top of the pelvis. The subQ fat was then calculated as the android fat -VAT mass. Each subject's measure of interest was reported in kilograms.
Glucose, Insulin, and Lipid Profile Assessment
All assays were conducted with standard procedures at a Centers for Disease Control and Prevention-certified laboratory. Fasting blood samples were collected for glucose, insulin, and lipid levels, including total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL). The LDL/HDL ratio was reported for each subject, because a higher ratio has been related to increased coronary heart disease risk.
12 Homeostatic model assessment (HOMA) of insulin resistance and b-cell function were calculated using fasting plasma insulin and fasting plasma glucose. 13 
Vascular Assessments
Vascular assessment was conducted for all participants following at least 8 hours of fasting. Subjects were required to refrain from caffeine ingestion within 4 hours prior to testing and avoid strenuous exercise or physical activity 24 hours prior to the study visit. Subjects were tested in a quiet, climate-controlled room (22-238C) . Resting blood pressure was recorded using an automated sphygmomanometer (Colin BP-8800; Colin Medical Instruments Corp., San Antonio, TX) on the right arm prior to FMD assessment. A specialized occlusion cuff (D.E. Hokanson, Inc., Bellevue, WA) was placed approximately 5 cm distal to the antecubital space on the left forearm. Following 15 minutes of quiet rest in the supine position, vascular images of the left brachial artery were obtained proximal to the antecubital fossa in the longitudinal plane using a conventional sonographic scanner (Acuson, Sequoia 512; Siemens Medical Solutions, Mountain View, CA) with a 8-15-MHz linear array probe held at a constant pressure on the skin and at a fixed point over the imaged artery by a stereotactic arm. The occlusion cuff on the left forearm was then inflated to a suprasystolic pressure level of 200 mmHg and maintained for 5 minutes. Vascular images were captured 20 seconds prior to cuff release until 3 minutes after cuff release and were digitized and stored on a personal computer for later analysis using an electronic wall-tracking software program (Vascular Research Tools 5; Medical Imaging Application, LLC, Iowa City, IA).
A trained sonographer performed all digital sonographic image capturing and analysis. The coefficient of variation was 11.1% in our laboratory when FMD was measured 7 days apart, demonstrating good reproducibility. Vascular images were assessed for brachial artery baseline diameter, maximal blood flow, peak shear, and subsequent brachial artery constriction and dilation. The baseline brachial artery measurement was defined as a 10-second average just prior to blood pressure cuff release (ie, occlusion baseline) to negate any low-flow-mediated constriction that may occur during occlusion. Maximal blood flow (m/s) was defined as the largest 10-second average rate of blood flow following 3 seconds after cuff release. Peak shear was used to estimate the greatest shear stress during the same timeframe as maximal blood flow. Peak shear was calculated as a 10-second average during postocclusive reactive hyperemia, which was calculated as blood flow velocity (q) divided by arterial diameter (D). H-FMC was observed and characterized using a 10-second average of the lowest point from baseline brachial artery diameter following 3-seconds after cuff release and considered present if the percent change was less than 20.1% ( Figure 1 ). Peak dilation during each procedure was defined as the 10-second average of the greatest percent change from baseline brachial artery diameter. The time that elapsed between cuff release and greatest constriction in H-FMC individuals was recorded as time-to-trough FMC (TTT FMC). There was no observed constriction in non-H-FMC individuals following cuff release, so TTT FMC was not applicable for the non-H-FMC group. The time between cuff release and peak dilation was recorded as time-to-peak FMD (TTP FMD).
Statistical Analysis
Statistical analysis was performed using SPSS Statistics 22 (IBM SPSS, Armonk, NY). Descriptive statistics were conducted for the two groups on anthropometrics, biomarkers of cardiovascular and metabolic risk, and FMD measurements. Allometric scaling was performed for FMD related to baseline brachial artery diameter as proposed by Atkinson et al, 14, 15 The comparison of the blood pressure and blood profile between H-FMC and non-HFMC groups is represented in Table 2 . There was no significant difference between groups for systolic and diastolic blood pressure, glucose, insulin, HOMA, total cholesterol, triglycerides, HDL, or LDL. However, LDL/HDL was significantly greater in H-FMC than in non-H-FMC subjects (Table 2 ), but not significantly correlated with H-FMC (r 5 20.111, p 5 0.087). Table 3 displays the study population's vascular measures. Baseline brachial artery diameter in H-FMC individuals was not significantly different from non-H-FMC individuals. In H-FMC individuals, the average TTT FMC was 10.2 6 4.9 seconds. Peak shear, maximal flow, and TTP FMD were not significantly different between H-FMC and non-H-FMC adults. FMD response was significantly greater in non-H-FMC individuals and did not change when using allometric scaling. However, when the magnitude of H-FMC was added to FMD in the H-FMC group, there was no longer a significant difference in response to reactive hyperemia p 5 0.048) was positively associated with peak FMD.
DISCUSSION
We observed that approximately 69% of the study population displayed H-FMC. Individuals that displayed an H-FMC had a lower peak FMD from an occlusion baseline compared with individuals not displaying an H-FMC. Also, H-FMC individuals had a significantly greater total body mass, BMI, fat mass, bone mass, android fat, gynoid fat, subQ fat and LDL/HDL than non-H-FMC individuals.
We have previously demonstrated that H-FMC prevalence in children and adolescents was approximately 67%, 4 which is very similar to the prevalence observed in adults in the present study. The significant presence of an initial constrictive response to reactive hyperemia in these studies should alert researchers utilizing FMD methodology to the possibility of a blunted peak FMD when using a baseline artery diameter measured before occlusion-cuff release. However, when the percent of H-FMC is added to peak FMD, the difference between the two groups becomes negligible. This finding is consistent with our previous research in children and adolescents. 4 Addition of this H-FMC may be a better measure of true NO-mediated dilation, because dilation would be assessed from the lowest artery diameter. Thus, researchers could use a baseline diameter measure that occurs after the occlusion cuff has been released. It would appear that an appropriate timeframe for calculation of a 10-second average baseline diameter following occlusion would be between 5 and 15 seconds, because the average TTT FMC was at 10 seconds. This is in contrast to previous research showing that using a universal baseline diameter calculated following occlusion cuff did not produce practical differences in FMD. 16 Flow-mediated dilation has been utilized as a measure of endothelial function and predictor of atherosclerotic development 17 and cardiovascular events in asymptomatic subjects. 18 A larger FMD response is generally associated with healthy endothelial function. In the current study, non-H-FMC adults displayed brachial artery FMD levels similar to those of healthy control subjects in other studies, 19, 20 whereas H-FMC individuals had a significantly lower FMD response. Even though the increased magnitude of an H-FMC was mildly associated with lower FMD response, it is unclear whether an H-FMC is an independent risk factor of endothelial dysfunction.
Age, blood pressure, peak shear, maximal flow, and baseline brachial artery diameter were not significantly different between H-FMC and non-H-FMC groups, also consistent with prior findings in children. 4 However, contrary to the findings in children and adolescents, total body mass and BMI were significantly higher in the adult H-FMC group than in the non-H-FMC group. Because body composition was assessed by DXA in the current study and not in our previous research, more precise weight-related factors were found that appeared to be significantly higher in the adult H-FMC group: fat mass, android fat, gynoid fat, subQ fat, and bone mass. These data would suggest that body composition has a greater influence on H-FMC in adults than other cardiovascular and metabolic risk factors because the LDL/HDL ratio was the only significant cardiovascular or metabolic factor significantly different between groups. However, the correlation of total body mass and BMI with H-FMC was relatively weak. Previous research has demonstrated lower FMD in abdominally obese individuals than in lean individuals, suggesting impaired endothelial function associated with android fat. 19, 21 Furthermore, modest increases in visceral fat as opposed to subQ fat have resulted in impaired endothelial function. 22 However, android fat, gynoid fat, and subQ fat were significantly elevated in the H-FMC group in the current study. Historically, gynoid and subQ fat have been considered to be lower health risks than VAT and android fat. 23 Lower extremity adiposity, specifically larger subQ thigh fat, has even been Values are mean 6 SD. Maximal flow (m/s) is a measure of average blood flow following cuff release.
Abbreviations: TTP FMD, time-to-peak FMD from cuff release to peak dilation; FMD, flow-mediated dilation; H-FMC, high-flow-mediated constriction; non-H-FMC, no high-flow-mediated constriction.
*Scaled flow-mediated dilation, % refers to Allometric scaling. associated with lowering potential health risks. 24 A positive correlation was found between gynoid fat and FMD in the current study, which is consistent with the notion of gynoid fat-lowering potential risk. Bone mass was also greater in the H-FMC than in the non-H-FMC group. Because a greater percentage of obese subjects were in the H-FMC group, a difference in bone mass between groups due to the well-established positive effect that increased mechanical loading, via body weight, has on bone formation, would be expected. 25 Overweight and obesity have been associated with enhanced endothelin-1-mediated vasoconstriction, 26 and a large percentage of obese individuals in the current study displayed an H-FMC. H-FMC, in some adults, may be due to increased amount of a flow-mediated constriction factor following cuff release. Because H-FMC was significantly correlated to an increased BMI and body mass, it could be possible that an enhanced endothelin-1-mediated response is partially involved in the H-FMC. However, endothelin-1 was not measured, and both BMI and body mass showed a relatively weak correlation with H-FMC.
Another point of interest in the current research is the lack of significant differences between groups for many known cardiovascular risk factors. Previous research has reported that many of the known cardiovascular risk factors, such as dyslipidemia, 27 diabetes mellitus, 28 hypertension, 29 and central obesity (waist circumference and VAT) 23, 30, 31 are associated with altered FMD. Of the known cardiovascular risk factors, the LDL/ HDL ratio was the only non-weight-related factor statistically significant between the H-FMC and non-H-FMC groups. However, a larger LDL/HDL ratio has been reported to be associated with a greater BMI. 32 Therefore, the development of abdominal obesity may precede the occurrence or detectability of lipid profile worsening or other cardiovascular risk factors.
In the current study, there was homogeneity of the study participants for many of the cardiovascular risk factors due to their healthy control status in the overarching study. This homogeneity of participants could be interpreted as a limitation. On the contrary, the presence of an H-FMC may be an independent factor for cardiovascular risk because homogeneity regarding known cardiovascular risk did not hinder the observation of H-FMC and non-H-FMC responses to reactive hyperemia. Instead, there were significant correlations between H-FMC, total body mass, and BMI and many other weight-related factors trending toward significance. Previous research has suggested that central obesity appears to precede the appearance of hypertension, glucose abnormalities, and dyslipidemia. 33 Thus, H-FMC could possibly be either a complementary health assessment tool to FMD or an insignificant artifact. A greater understanding of H-FMC should be achieved with future longitudinal research, including H-FMC magnitude with FMD methodology.
Of interest, all of the H-FMC correlations with body composition were significant in females, but not in males. This could be due to hormonal differences between genders. However, the significant correlations found in females between body composition and H-FMC remained weak.
It has been posed that FMD, and subsequently H-FMC, needs to be scaled to account for the reliance on baseline diameter in FMD calculation. 14, 15 However, allometric scaling did not change the difference between groups for FMD in the present study (Table 3) . Furthermore, allometric scaling of H-FMC did not comply with the criteria outlined in previous research. 14, 15 Historically, the benefit of FMD testing is the simplistic and noninvasive nature of the procedure. Taking into account the presence of an H-FMC does complicate the analysis of FMD, as does allometric scaling, 14, 15 but it also adds to the body of FMD research. The time to reach peak dilation for both groups is similar, which seems to imply that endothelial NO and other dilating factors are secreted for a set amount of time in adults. Because body mass and BMI seem to have a significant, but weak correlation with the prevalence of vasoconstriction observed postocclusion (Figure 2 ), H-FMC may be a possible independent indicator of vascular remodeling. Obesity could be an extrinsic factor associated with endothelial dysfunction, whereas an H-FMC may be an intrinsic sign of vascular dysfunction. However, this hypothesis will need to be examined in future studies.
The present study is subject to a few limitations. Intra-arterial pressure and vasoconstrictor mediators were not directly measured. The possibility of autonomic nervous system contribution to H-FMC was also not investigated. The cross-sectional nature of the study also does not answer the reproducibility of the H-FMC response to blood flow manipulation. Future studies should investigate both children and adult cohorts for the reproducibility in the presence and magnitude of an H-FMC. Also, at-risk and diseased populations should be investigated for prevalence of an H-FMC. The investigation of inflammatory and other ancillary blood markers associated with an H-FMC would also be beneficial. A prospective study would be required to determine the reproducibility, validity, and physiologic modification of an H-FMC as a risk factor for atherosclerosis and cardiovascular disease.
CONCLUSION
An H-FMC occurred in a majority of healthy adults during reactive hyperemia, and FMD was lower in adults who experience H-FMC, suggesting the presence of endothelial dysfunction. Because a greater percentage of children, adolescents, 4 and adults seem to display an H-FMC following occlusion, using a postocclusion baseline may be worth consideration in future FMD studies. Increased body mass and BMI were associated with a greater H-FMC. However, it is currently unknown whether H-FMC has any clinical implications. Nevertheless, our findings suggest that this H-FMC should be considered when analyzing and interpreting FMD data. Future studies should examine the reproducibility, validity, and reliability of H-FMC and changes in body composition, specifically body mass and fat mass, on H-FMC magnitude in children and adults.
